| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ad9ba0a10963b0417e6ca5f79d1db4ba |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A63B2009-006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A63B2009-002 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A63B9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A63B69-0048 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195 |
| filingDate |
2006-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27ed03faeca3bf52af6455abeb0e57ba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_672130b3310f6fc5c67b51f63abe4d25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58f0b31da708d684a3b2531679ccc584
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b21e6ae8b66ee3b5bc53ab46e2a9aa28 |
| publicationDate |
2006-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20060085173-A |
| titleOfInvention |
Two-Day Oral Dosage Formulation |
| abstract |
The present invention provides an oral dosage formulation which can exert the maximum therapeutic effect against pigmentation caused by blotch, freckles, sunburn or skin disease in a formulation containing L-cysteine and ascorbic acid. It relates to a cysteine or a salt thereof and ascorbic acid or a salt thereof, and relates to a twice-daily oral dosage form characterized in that the single dose of L-cysteine is 90 to 150 mg. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101237498-B1 |
| priorityDate |
2005-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |